Description
Added on the 23/04/2021 16:35:28 - Copyright : AFPTV - First images
Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE
The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age, despite links to blood clots. SOUNDBITE
The benefits of AstraZeneca's coronavirus vaccine outweigh the risks, World Health Organization (WHO) experts have concluded. The statement followed the European Medicines Agency (EMA) giving their green light to the vaccine on Thursday. IMAGES
The EU's drug regulator says it remains "firmly convinced" of the benefits of AstraZeneca's coronavirus vaccine despite several countries suspending its use over blood clot fears. SOUNDBITE
EMA Executive Director Emer Cooke says an immune response is a 'plausible' explanation for blood clots resulting from the AstraZeneca coronavirus vaccine. SOUNDBITE